Singapore-based HealthXCapital today launched what it claims to be the first healthcare-focused, early-stage fund for emerging markets in Asia.
The US$25 million fund is backed by Indian hospital chain Apollo Hospitals, Eight Roads Ventures – an investment unit of Bermuda-based Fidelity International, Singaporean VC firm Jungle Ventures, and other private investors.
The VC’s investment focus is on “point-of-care diagnostics, medical devices, as well as digital and AI health solutions” that will help bring down healthcare costs and improve patient outcomes.
“Access to quality healthcare that’s affordable is probably the most pressing challenge in Asia’s healthcare system,” says Jauhari.
“Given that the traditional brick-and-mortar models have scale limitations, we believe technology has a significant role [to play].”
HealthXCapital has already made investments through the fund.